Proton pump inhibitors exert anti-allergic effects by reducing TCTP secretion
- PMID: 19484128
- PMCID: PMC2684640
- DOI: 10.1371/journal.pone.0005732
Proton pump inhibitors exert anti-allergic effects by reducing TCTP secretion
Abstract
Background: Extracellular translationally controlled tumor protein (TCTP) is known to play a role in human allergic responses. TCTP has been identified outside of macrophages, in activated mononuclear cells, and in biological fluids from allergic patients. Even TCTP devoid of signal sequences, is secreted to extracellular environment by an yet undefined mechanism. This study is aimed at understanding the mechanism of TCTP release and its regulation. A secondary goal is to see if inhibitors of TCTP release can serve as potential anti-allergic asthmatic drugs.
Methodology/principal findings: Using Western blotting assay in HEK293 and U937 cells, we found that TCTP secretion is reduced by omeprazole and pantoprazole, both of which are proton pump inhibitors. We then transfected HEK293 cells with proton pump expression vectors to search for the effects of exogeneously overexpressed H(+)/K(+)-ATPase on the TCTP secretion. Based on these in vitro data we checked the in vivo effects of pantoprazole in a murine model of ovalbumin-induced allergy. Omeprazole and pantoprazole reduced TCTP secretion from HEK293 and U937 cells in a concentration-dependent fashion and the secretion of TCTP from HEK293 cells increased when they over-expressed H(+)/K(+)-ATPase. In a murine model of ovalbumin-induced allergy, pretreatment with pantoprazole reduced infiltration of inflammatory cells, increased goblet cells, and increased TCTP secretion induced by OVA challenge.
Conclusion: Since Omeprazole and pantoprazole decrease the secretion of TCTP which is associated with the development of allergic reaction, they may have the potential to serve as anti-allergic (asthmatic) drugs.
Conflict of interest statement
Figures
Similar articles
-
Targeting the translationally controlled tumor protein by a monoclonal antibody improves allergic airway inflammation in mice.Biomed Pharmacother. 2023 Dec;168:115655. doi: 10.1016/j.biopha.2023.115655. Epub 2023 Oct 6. Biomed Pharmacother. 2023. PMID: 37806090
-
Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.Naunyn Schmiedebergs Arch Pharmacol. 2001 Dec;364(6):551-7. doi: 10.1007/s00210-001-0489-7. Naunyn Schmiedebergs Arch Pharmacol. 2001. PMID: 11770010
-
The basis of differentiation of PPIs.Drugs Today (Barc). 2004 Mar;40 Suppl A:9-14. Drugs Today (Barc). 2004. PMID: 15190382 Review.
-
Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.Biochem Pharmacol. 1999 Oct 15;58(8):1349-59. doi: 10.1016/s0006-2952(99)00211-7. Biochem Pharmacol. 1999. PMID: 10487539
-
Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.J Am Pharm Assoc (Wash). 2000 Jan-Feb;40(1):52-62; quiz 121-3. doi: 10.1016/s1086-5802(16)31036-1. J Am Pharm Assoc (Wash). 2000. PMID: 10665250 Review.
Cited by
-
Radiosensitivity of Cancer Cells Is Regulated by Translationally Controlled Tumor Protein.Cancers (Basel). 2019 Mar 19;11(3):386. doi: 10.3390/cancers11030386. Cancers (Basel). 2019. PMID: 30893896 Free PMC article.
-
TAZ deficiency exacerbates psoriatic pathogenesis by increasing the histamine-releasing factor.Cell Biosci. 2024 May 11;14(1):60. doi: 10.1186/s13578-024-01246-0. Cell Biosci. 2024. PMID: 38734624 Free PMC article.
-
Translationally controlled tumor protein: the mediator promoting cancer invasion and migration and its potential clinical prospects.J Zhejiang Univ Sci B. 2022 Aug 15;23(8):642-654. doi: 10.1631/jzus.B2100910. J Zhejiang Univ Sci B. 2022. PMID: 35953758 Free PMC article. Review.
-
Translationally controlled tumour protein (TCTP) is present in human cornea and increases in herpetic keratitis.Diagn Pathol. 2012 Aug 1;7:90. doi: 10.1186/1746-1596-7-90. Diagn Pathol. 2012. PMID: 22853445 Free PMC article.
References
-
- Nielsen H, Johnsen A, Sanchez J, Hochstrasser D, Schiøtz P. Identification of a basophil leukocyte interleukin-3-regulated protein that is identical to IgE-dependent histamine-releasing factor. Allergy. 1998;53:642–652. - PubMed
-
- Teshima S, Rokutan K, Nikawa T, Kishi K. Macrophage colony-stimulating factor stimulates synthesis and secretion of a mouse homolog of a human IgE-dependent histamine-releasing factor by macrophages in vitro and in vivo. J Immunol. 1998;161:6356–6366. - PubMed
-
- MacDonald S, Rafnar T, Langdon J, Lichtenstein L. Molecular identification of an IgE-dependent histamine-releasing factor. Science. 1995;269:688–690. - PubMed
-
- Liu M, Proud D, Lichtenstein L, MacGlashan D, Schleimer R, et al. Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. J Immunol. 1986;136:2588–2595. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources